Low vitamin D linked to worse prognosis in type of non-Hodgkin lymphoma

March 30, 2015, University of Rochester Medical Center

A new study found that people with lower vitamin D levels prior to treatment for follicular lymphoma succumb to the disease or face relapse earlier than patients with sufficient vitamin D levels in their blood.

The Wilmot Cancer Institute investigation is believed to be the first to report that lack of D is a potentially modifiable risk factor for this type of cancer. The study was published by the Journal of Clinical Oncology.

Vitamin D's connection to cancer is an active research topic. Prior studies have shown a survival benefit among patients with higher vitamin D levels for diffuse large B-cell lymphoma and chronic lymphocytic leukemia. In addition, earlier peer-reviewed research at Wilmot showed that low vitamin D levels among women with breast cancer correlated with more aggressive tumors and poorer prognosis; and that vitamin D deficiency among African Americans might help to explain higher death rates from colorectal cancer. Currently, Wilmot investigators are evaluating whether weekly, high doses of vitamin D (50,000 IU) improves the side effects related to androgen deprivation therapy for prostate cancer in patients ages 65 and older.

Jonathan W. Friedberg, M.D., director of the Wilmot Cancer Institute, and Jennifer Kelly, M.P.H., Ph.D., an epidemiologist at the University of Rochester School of Medicine and Dentistry, led the collaborative follicular lymphoma study between SWOG, a component of the NCI-sponsored National Clinical Trials Network, and the Lymphoma Study Association (LYSA), based in France.

Researchers observed a total of 423 follicular lymphoma patients in two independent cohorts, who were followed for a minimum of 5 ½ years each. They measured the patients' baseline vitamin D blood levels before began, and then tracked and analyzed cancer survival data for each group.

Future research might support prescribing vitamin D supplements for patients at the earliest point of follicular lymphoma treatment, when patients are typically monitored closely but have not started active therapy, investigators concluded. They also suggested that vitamin D may represent a proxy or biomarker for better health going into cancer treatment.

Follicular lymphoma is generally incurable although it's slow-growing and many people live for years with the disease. Risk increases with age, and an estimated 19,000 people annually are diagnosed with FL. Treatments have improved recently, although a subset of patients have an aggressive form for which therapy is not as effective. Better ways to predict the course of the disease are needed, therefore—and this is where vitamin D levels might provide a previously unidentified but modifiable factor associated with prognosis, Friedberg said.

"Our data, replicated internationally, supports other published observations linking Vitamin D deficiency with inferior outcomes," he said. "However, the mechanisms of this link are likely complex and require further study."

Large differences in vitamin D levels among the patients in the two cohorts prevented scientists from being able to recommend an optimal level of vitamin D for patients. (In the U.S., vitamin D sufficiency is usually defined as 25 mg/ml.) Geographic regions (including less sunny climates) and ethnicity and genetics (African Americans often have lower levels that other races) influence baseline vitamin D levels in people to a great extent, and would impact a threshold level.

Explore further: Vitamin D may raise survival rates among cancer patients

Related Stories

Vitamin D may raise survival rates among cancer patients

April 29, 2014
Cancer patients who have higher levels of vitamin D when they are diagnosed tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study published in ...

Sunshine vitamin ups bowel cancer survival odds, study finds

July 9, 2014
Bowel cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows.

Vitamin D may help prevent and treat diseases associated with aging, study finds

March 17, 2015
Vitamin D may play a vital role in the prevention and treatment of diseases associated with aging, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON). These findings were published ...

High levels of vitamin D is suspected of increasing mortality rates

March 10, 2015
The level of vitamin D in our blood should neither be too high nor to low. Scientists from the University of Copenhagen are the first in the world to show that there is a connection between high levels of vitamin D and cardiovascular ...

Vitamin D protects against colorectal cancer by boosting the immune system

January 15, 2015
A new study by Dana-Farber Cancer Institute investigators demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system's vigilance against tumor cells.

Vitamin D may play an important role in cancer prognosis

June 17, 2014
Researchers have found that people with very low levels of vitamin D appear to be at higher risk of death from all causes (including cancer) and say that vitamin D could play an important role in cancer prognosis in a paper ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.